Lucid Diagnostics Announces Peer-Reviewed Publication of Real-World Clinical Data

Article summary

Lucid Diagnostics, a subsidiary of PAVmed Inc., announced the publication of findings from the largest real-world clinical study of its nonendoscopic esophageal precancer testing.